Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4

Telmikind-Trio 6.25 Tablet

Prescription Icon
Prescription Required

Marketer

Mankind Pharma Ltd

Salt Composition

Telmisartan (40mg) + Cilnidipine (10mg) + Chlorthalidone (6.25mg)

Overview Telmikind-Trio 6.25 Tablet

Trikind-Combo 6.25mg tablets combine medications to manage hypertension when monotherapy proves insufficient. This formulation lowers elevated blood pressure, decreasing the risk of future stroke and heart attack. Take Trikind-Combo 6.25mg with food, at the same time daily, as prescribed by your physician. Consistent use is vital; discontinue only as directed. The diuretic component may increase urination; avoid dosing within four hours of bedtime. Regular intake maximizes benefits, even during symptom-free periods; uncontrolled hypertension is often asymptomatic, and cessation increases stroke/heart attack risk. Common side effects include ankle edema, headache, dizziness, fatigue, and altered taste. Report persistent, worsening, or bothersome side effects to your doctor. Maintain adequate hydration to mitigate potential muscle weakness, dry mouth, or thirst. Inform your doctor of pre-existing liver or kidney issues, pregnancy, breastfeeding, and all other medications, particularly cardiovascular or antihypertensive drugs. Regular monitoring of blood pressure, kidney function, electrolytes, and blood glucose levels is crucial to assess treatment efficacy.

Primary Ingredients of Telmikind-Trio 6.25 Tablet

No text was provided. Please provide the text you wish me to rewrite.

Uses of Telmikind-Trio 6.25 Tablet

Elevated arterial pressure

Major Benefits of Telmikind-Trio 6.25 Tablet:

Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telmikind-Trio 6.25 Tablet with food.

Common Side effects of Telmikind-Trio 6.25 Tablet:

  • Ankle swelling
  • Headache
  • Dizziness
  • Tiredness
  • Palpitations
  • Sleepiness
  • Increased blood uric acid
  • Glucose intolerance
  • Taste change
  • Flushing (sense of warmth in the face, ears, neck and trunk)
  • Upset stomach
  • Altered blood lipid level

How to use Telmikind-Trio 6.25 Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmikind-Trio 6.25 Tablet whole; avoid crushing, chewing, or breaking it. Administer this medicine with food.

How Telmikind-Trio 6.25 Tablet works:

Telmisartan, Cilnidipine, and Chlorthalidone, combined as Telmikind-Trio 6.25 Tablet, offer a three-pronged approach to blood pressure management. Telmisartan, an angiotensin receptor blocker (ARB), and Cilnidipine, a calcium channel blocker (CCB), act synergistically to dilate blood vessels, thus reducing blood pressure. The diuretic Chlorthalidone facilitates the excretion of excess fluid and electrolytes, further contributing to vasodilation and improved circulation.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Telmikind-Trio 6.25 Tablet is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Telmikind-Trio 6.25 Tablet during pregnancy poses a confirmed risk to the fetus. Its use should be avoided except in extreme circumstances where a physician deems the potential benefits outweigh the known dangers to the mother's life. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the safety of Telmikind-Trio 6.25 Tablet while breastfeeding is lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking Telmikind-Trio 6.25 Tablet may cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.

KidneyKidneyCAUTION

Patients with severe kidney impairment should exercise caution when using Telmikind-Trio 6.25mg tablets, as dose modification may be necessary. Physician consultation is advised; administration is generally not recommended for such individuals.

LiverLiverCAUTION

Patients with liver impairment should use Telmikind-Trio 6.25mg tablets cautiously, potentially requiring dosage modification under medical supervision. The medication is contraindicated in individuals with severe hepatic dysfunction.

What if you forget to take Telmikind-Trio 6.25 Tablet :

Should you forget a Telmikind-Trio 6.25 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Telmikind-Trio 6.25 Tablet

LabelValue
Developing Habits No.
Treatment Category Heart
Telmikind-Trio 6.25 Table...
99
MRP 121
18% off